Anove LogoAnove LogoExplAIn
MapsAI frontrunners
Back to Directory

Corsano CardioWatch

by Corsano Health

AI Application
Low Confidence

Corsano CardioWatch 287-2 is a prescription wrist-worn device for continuous remote monitoring of vital signs in hospital wards and at home, used by clinical teams who follow patients through Corsano's web portal or an integration. The instructions for use say it collects heart rate, heart-rate variability, respiration rate, SpO2, temperature, activity, sleep, ECG and cuffless blood pressure (after cuff calibration) with proprietary signal-processing algorithms, raises visual and audible physiological alerts that can be adjusted per patient, and offers rhythm classification (with Preventicus) and a cloud ECG algorithm (by Cardiolyse) whose results are potential findings, not a diagnosis. Separately, the vendor describes a Corsano Early Warning Score (Cor-EWS) that it says uses machine learning and AI on the raw data streams to detect and predict clinical deterioration, with versions for sepsis and CAR-T therapy in development; it does not say whether Cor-EWS is part of the CE-marked device. Data go to Corsano's cloud on Amazon Web Services; the region is not stated.

Visit Website

Transparency Score

Weighted across four pillars · updated October 20, 2026

Overall grade
60% weighted
ABCDF
Model
—
Not yet assessed

Capabilities

Continuous Vital Sign Monitoring
Threshold Alerting
Arrhythmia Classification
Cuffless Blood Pressure
Early Warning Scoring
Remote Patient Monitoring

Vendor Information

Complete information about the vendor/provider of this AI application

Corsano HealthView all products →
Corsano Health B.V.(Trading as: Corsano Health)
Contact Information
corsano.com/
privacy@corsano.com
+31 6 84 46 85 22
Registered Address
Waldorpstraat 5, Den Haag, Zuid-Holland, 2521 CA, NL

Infrastructure

Platforms hosting this application — each inherits its own transparency grade.

Amazon Web Services (AWS)
Amazon
F
View full infrastructure →

EU AI Act Provider Information

Verification Status:
Verified
Corsano Health B.V.(Trading as: Corsano Health)
Waldorpstraat 5, Den Haag, Zuid-Holland, 2521 CA, NL
privacy@corsano.com+31 6 84 46 85 22
Compliance Documents
CE Marking: Certified
Instructions for Use
Notified Body: Kiwa Assurance B.V.(Cert: 24M00106CRT02)
The CardioWatch 287-2 instruction manual (revision 16, 22 June 2024) says the system is not intended for high-acuity settings such as an ICU or operating room, not for acutely ill cardiac patients who may develop life-threatening arrhythmias (it does not replace an ECG monitor), and not for SpO2 monitoring under high motion or low perfusion; its rhythm interpretations are potential findings, not a full diagnosis, and users must consult a healthcare professional before acting; cuffless blood pressure needs calibration with a cuff monitor. Source: https://corsano.com/wp-content/uploads/2024/08/ENG-IFU-Corsano-CardioWatch-287-2-Bracelet-v16.pdf (read 2026-10-20).

Supply Chain Network

Visual representation of the vendor's digital supply chain relationships

Compliance & Risk

Get insights into risk by running assessments on this AI application.

Work at Corsano Health? Claim this listing to correct or complete the data.

Added: September 10, 2026
Updated: October 20, 2026

Ready to manage AI applications?

Track, assess, and govern your AI applications with Anove.

Anove LogoAnove LogoAnove International B.V.

Helping organizations discover and manage AI applications responsibly. Your trusted source for AI governance and compliance.

Quick Links

  • Browse Directory
  • FAQ
  • AI maps by industry
  • Sign In

Resources

  • Documentation
  • Status
  • Anove.ai

Terms

  • Privacy Policy
  • Terms & Conditions
  • Responsible Disclosure
  • AI Legal Notice
  • Security Policy

© 2026 Anove International B.V. All rights reserved.